Clinical Trial

Study to Evaluate the Safety and Effectiveness of GP0116

Study acronym: NLF
Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
This is a prospective, randomized, evaluator-blinded, comparator-controlled, parallel group, multicenter study in the U.S. for correction of moderate to severe dynamic facial wrinkles and folds, such as nasolabial folds (NLFs).
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2023-08-09; most recent amendment 2025-06-26.
Trial Details
NCT Number NCT05987163
Lead Sponsor Galderma R&D
Conditions Skin Manifestations
Enrollment 186 participants
Start Date 2023-04-12
Primary Completion 2024-10-29 (estimated)
Study Completion 2026-03-31 (estimated)
Updated on ClinicalTrials.gov 2025-07-02